PPIs: Fears Persist Despite Little Evidence for Risks

A number of high-profile, but ultimately weakly associated, risks have hounded proton pump inhibitors for years. The mainstream media caught on to research that linked the drugs to scary conditions such as dementia, myocardial infarction and even malignancies causing some patients to discontinue them entirely. However, new research over the last several years has either disproven those previous claims or found the associations to be extremely weak. How can the gastroenterology community rebuild the image of PPIs?A possible link between PPI use and dementia received a great deal of mediaRead More

Share on facebook
Share on twitter
Share on linkedin